EML4/ALK and Ras Inhibitors

被引：0
|
作者：
Edelman, Martin J. [1 ]
机构：
[1] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2010年 / 5卷 / 12期
关键词：
CELL LUNG-CANCER; EML4-ALK; IDENTIFICATION;
D O I：
10.1097/01.JTO.0000391381.40050.5c
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：S495 / S496
页数：2
相关论文
共 50 条
  • [31] New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients
    Villa, Matteo
    Malighetti, Federica
    Sala, Elisa
    Sharma, Geeta G.
    Arosio, Giulia
    Gemelli, Maria
    Manfroni, Chiara
    Fontana, Diletta
    Cordani, Nicoletta
    Meneveri, Raffaella
    Zambon, Alfonso
    Piazza, Rocco
    Pagni, Fabio
    Cortinovis, Diego
    Mologni, Luca
    NPJ PRECISION ONCOLOGY, 2024, 8 (01)
  • [32] EML4–ALK rearrangement in squamous cell carcinoma shows significant response to anti-ALK inhibitor drugs crizotinib and alectinib
    Thomas Huang
    Brigitte J. Engelmann
    Rachael M. Morgan
    Kimberly J. Absher
    Jill M. Kolesar
    John L. Villano
    Cancer Chemotherapy and Pharmacology, 2018, 81 : 965 - 968
  • [33] New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients
    Matteo Villa
    Federica Malighetti
    Elisa Sala
    Geeta G. Sharma
    Giulia Arosio
    Maria Gemelli
    Chiara Manfroni
    Diletta Fontana
    Nicoletta Cordani
    Raffaella Meneveri
    Alfonso Zambon
    Rocco Piazza
    Fabio Pagni
    Diego Cortinovis
    Luca Mologni
    npj Precision Oncology, 8
  • [34] SMARCB1-deficient renal medullary carcinoma with an EML4::ALK fusion gene in a Japanese woman
    Nobuoka, Megumi
    Mukawa, Tatsuya
    Iwaya, Mai
    Shigeto, Shohei
    Minagawa, Tomonori
    Uehara, Takeshi
    Akiyama, Yoshiyuki
    PATHOLOGY INTERNATIONAL, 2024, 74 (12) : 704 - 707
  • [35] EML4-ALK
    Solomon, B.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (03) : S18 - S18
  • [36] Human EML4 - A novel member of the EMAP family
    Heidebrecht, HJ
    Pollmann, M
    Kruse, ML
    Buck, F
    Parwaresch, R
    EUROPEAN JOURNAL OF CELL BIOLOGY, 2004, 83 : 75 - 75
  • [37] 非小细胞肺癌ALK融合基因非EML4伙伴的故事
    魏雨晴
    许春伟
    宋勇
    循证医学, 2018, 18 (05) : 257 - 259
  • [38] Overcoming the resistance to Crizotinib in patients with Non-Small Cell Lung Cancer harboring EML4/ALK translocation
    Perez, Cesar A.
    Velez, Michel
    Raez, Luis E.
    Santos, Edgardo S.
    LUNG CANCER, 2014, 84 (02) : 110 - 115
  • [39] EML4/ALK Status in Lung Cancer - A 2 Year Experience from a Tertiary Care Cancer Centre in India
    Murthy, Sudha S.
    Rajappa, Senthil J.
    Gundimeda, Sandhya D.
    Mallavarapu, Krishna M.
    Ayyagari, Santa
    Raju, K. V.
    Rao, Thamineedi S.
    Fonseca, Daphne
    Koppula, Veeraiah
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S693 - S693
  • [40] A Polytherapy Strategy Using Vincristine and ALK Inhibitors to Sensitise EML4-ALK-Positive NSCLC
    Sampson, Josephina
    Ju, Hyun-min
    Song, Ji-young
    Fry, Andrew M.
    Bayliss, Richard
    Choi, Jene
    CANCERS, 2022, 14 (03)
12345